1.
Gunturu K, Abu-KhalafM, Saif M. Hepatic Failure and Hepatorenal Syndrome Secondary to Erlotinib: A Possible Etiology of Complications in a Patient with Pancreatic Cancer. JOP [Internet]. 6Sep.2010 [cited 3May2024];11(5):484-5. Available from: http://www.serena.unina.it/index.php/jop/article/view/3443